Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
October 16, 2018
Distinct microglia profile in Creutzfeldt-Jakob disease and Alzheimer's disease is independent of disease kinetics
Katarina Krbot, Peter Hermann, Magdalena Krbot Skorić, et al.
Journal of Neuroinflammation
|
July 14, 2019
Plasma YKL-40 in the spectrum of neurodegenerative dementia
Anna Villar-Piqué, Matthias Schmitz, Peter Hermann, et al.
Neurology
|
June 24, 2018
Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance
Peter Hermann, Mareike Laux, Markus Glatzel, et al.
Journal of Neurology
|
January 9, 2023
Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance
Peter Hermann, Matthias Schmitz, Maria Cramm, et al.
Diagnostics (Basel, Switzerland)
|
May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline
Anna Emdina, Peter Hermann, Daniela Varges, et al.
Journal of Neurochemistry
|
October 28, 2025
Multiple Antibody-Coated Gold Nanoparticle-Based ExoAssay for Rapid Isolation of CNS-Specific Exosomes From Blood
Leticia Camila Fernandez Flores, Neelam Younas, Stefan Goebel, et al.
Alzheimer'S Research & Therapy
|
January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers
Peter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Alzheimer'S Research & Therapy
|
June 8, 2023
Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease
Janne Marieke Herden, Peter Hermann, Isabel Schmidt, et al.
Nature Communications
|
February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Franc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 3, 2018
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
Inga Zerr, Matthias Schmitz, André Karch, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
October 16, 2018
Distinct microglia profile in Creutzfeldt-Jakob disease and Alzheimer's disease is independent of disease kinetics
Katarina Krbot, Peter Hermann, Magdalena Krbot Skorić, et al.
Journal of Neuroinflammation
|
July 14, 2019
Plasma YKL-40 in the spectrum of neurodegenerative dementia
Anna Villar-Piqué, Matthias Schmitz, Peter Hermann, et al.
Neurology
|
June 24, 2018
Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance
Peter Hermann, Mareike Laux, Markus Glatzel, et al.
Journal of Neurology
|
January 9, 2023
Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance
Peter Hermann, Matthias Schmitz, Maria Cramm, et al.
Diagnostics (Basel, Switzerland)
|
May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline
Anna Emdina, Peter Hermann, Daniela Varges, et al.
Journal of Neurochemistry
|
October 28, 2025
Multiple Antibody-Coated Gold Nanoparticle-Based ExoAssay for Rapid Isolation of CNS-Specific Exosomes From Blood
Leticia Camila Fernandez Flores, Neelam Younas, Stefan Goebel, et al.
Alzheimer'S Research & Therapy
|
January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers
Peter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Alzheimer'S Research & Therapy
|
June 8, 2023
Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease
Janne Marieke Herden, Peter Hermann, Isabel Schmidt, et al.
Nature Communications
|
February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Franc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 3, 2018
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
Inga Zerr, Matthias Schmitz, André Karch, et al.
Page
of 2